DD137710A5 - Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine - Google Patents

Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine

Info

Publication number
DD137710A5
DD137710A5 DD78206567A DD20656778A DD137710A5 DD 137710 A5 DD137710 A5 DD 137710A5 DD 78206567 A DD78206567 A DD 78206567A DD 20656778 A DD20656778 A DD 20656778A DD 137710 A5 DD137710 A5 DD 137710A5
Authority
DD
German Democratic Republic
Prior art keywords
cyanaziridine
acyl
preparation
new
Prior art date
Application number
DD78206567A
Other languages
English (en)
Inventor
Herbert Berger
Rudi Gall
Wolfgang Kampe
Uwe Bicker
Rolf Kuhn
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD137710A5 publication Critical patent/DD137710A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/18—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564—Three-membered rings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B3/00—Blasting cartridges, i.e. case and explosive
    • F42B3/087—Flexible or deformable blasting cartridges, e.g. bags or hoses for slurries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD78206567A 1977-07-11 1978-07-06 Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine DD137710A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772731264 DE2731264A1 (de) 1977-07-11 1977-07-11 Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
DD137710A5 true DD137710A5 (de) 1979-09-19

Family

ID=6013651

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78206567A DD137710A5 (de) 1977-07-11 1978-07-06 Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine

Country Status (26)

Country Link
US (1) US4267174A (de)
JP (1) JPS5436254A (de)
AT (1) AT356663B (de)
AU (2) AU519219B2 (de)
BE (1) BE868796A (de)
CA (1) CA1086309A (de)
CS (1) CS208656B2 (de)
DD (1) DD137710A5 (de)
DE (1) DE2731264A1 (de)
DK (1) DK306978A (de)
ES (1) ES471512A1 (de)
FI (1) FI782157A7 (de)
FR (1) FR2397403A1 (de)
GB (1) GB1594079A (de)
HU (1) HU179428B (de)
IL (1) IL55109A (de)
IT (1) IT1096910B (de)
LU (1) LU79937A1 (de)
NL (1) NL7807276A (de)
NO (1) NO782399L (de)
NZ (1) NZ187794A (de)
PL (1) PL126639B1 (de)
PT (1) PT68263A (de)
SE (1) SE7807642L (de)
SU (1) SU1077565A3 (de)
ZA (1) ZA783829B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2906603A1 (de) * 1979-02-21 1980-09-04 Boehringer Mannheim Gmbh N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
US4393000A (en) * 1979-12-12 1983-07-12 Mitsui Toatsu Chemicals, Inc. Cyclization process for producing aziridine-2-carboxylic acid or its salts
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
MXPA05007485A (es) * 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
ES2316964T3 (es) * 2003-02-24 2009-04-16 Arena Pharmaceuticals, Inc. Fenil-y piridilpipereidinia-derivados como moduladores del metabolismo de la glucosa.
AR045047A1 (es) * 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
EA011671B1 (ru) * 2004-06-04 2009-04-28 Арена Фармасьютикалз, Инк. Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
BRPI0616245A2 (pt) * 2005-09-16 2011-06-14 Arena Pharm Inc modulador de metabolismo, seus usos, composiÇço farmaceutica compreendendo o mesmo, bem como mÉtodo para produÇço da referida composiÇço
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
SG10201906876PA (en) 2010-01-27 2019-09-27 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
MX386419B (es) 2015-01-06 2025-03-18 Arena Pharm Inc Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
EP3939965A1 (de) 2015-06-22 2022-01-19 Arena Pharmaceuticals, Inc. Kristallines l-arginin-salz von (r)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)essigsäure zur verwendung in s1p1-rezeptor-assoziierten erkrankungen
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
ES2987794T3 (es) 2018-06-06 2024-11-18 Arena Pharm Inc Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1
LV15518A (lv) * 2019-02-18 2020-08-20 Latvijas Organiskās Sintēzes Institūts Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze
EP4087650A1 (de) * 2020-01-10 2022-11-16 Uniwersytet Jagiellonski Aromatische sulfonamidderivate, die pdi a1 hemmen, ihre synthese und verwendung
US20230039836A1 (en) * 2020-01-10 2023-02-09 Uniwersytet Jagiellonski Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD110492A1 (de) * 1974-03-21 1974-12-20
JPS5932772B2 (ja) * 1974-09-21 1984-08-10 旭光学工業 （株） 照射光走査装置
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans

Also Published As

Publication number Publication date
CS208656B2 (en) 1981-09-15
GB1594079A (en) 1981-07-30
JPS5436254A (en) 1979-03-16
ES471512A1 (es) 1979-10-01
PT68263A (de) 1978-08-01
IL55109A0 (en) 1978-09-29
AU3782678A (en) 1980-01-10
NL7807276A (nl) 1979-01-15
ATA496478A (de) 1979-10-15
AU3782578A (en) 1980-01-10
LU79937A1 (de) 1980-02-14
IT1096910B (it) 1985-08-26
US4267174A (en) 1981-05-12
HU179428B (en) 1982-10-28
ZA783829B (en) 1980-03-26
FR2397403A1 (fr) 1979-02-09
AU519219B2 (en) 1981-11-19
BE868796A (fr) 1979-01-08
DE2731264A1 (de) 1979-02-01
PL208195A1 (de) 1980-03-24
PL126639B1 (en) 1983-08-31
IL55109A (en) 1982-07-30
SE7807642L (sv) 1979-03-14
SU1077565A3 (ru) 1984-02-29
NO782399L (no) 1979-01-12
CA1086309A (en) 1980-09-23
DK306978A (da) 1979-01-12
IT7825474A0 (it) 1978-07-07
NZ187794A (en) 1980-05-08
FI782157A7 (fi) 1979-01-12
AT356663B (de) 1980-05-12

Similar Documents

Publication Publication Date Title
DD138544A5 (de) Verfahren zur herstellung von cyclopropanderivaten
DD137710A5 (de) Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine
DD134642A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
DD132869A5 (de) Verfahren zur herstellung neuer aminothiazolylazetamido-derivate
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
PT68044A (de) Verfahren zur herstellung neuer derivate des alkylendiami
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
AT365177B (de) Verfahren zur herstellung neuer 2-formylchinoxalin-1,4-dioxid-zyanacetylhydrazo e
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
DD131026A5 (de) Verfahren zur herstellung von methyldichlorphosphan
DD134351A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinonen
DD130240A5 (de) Verfahren zur herstellung von acylcyaniden
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
DD138774A5 (de) Verfahren zur herstellung neuer piperazinopyrrolobenzodiazepinen
DD134100A5 (de) Verfahren zur herstellung von lactamen
DD135497A5 (de) Verfahren zur herstellung von 17 beta hydroxy-4-androsten-3-onen
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
DD135384A5 (de) Verfahren zur herstellung von 2-hydroxybenzthiazol-verbindungen
DD135390A5 (de) Verfahren zur herstellung neuer aryl-hexafuranoside
DD134868A5 (de) Verfahren zur herstellung neuer 1-phenyl-2-amino-1,3-propandiol-n-alkyl-derivate
DD128852A5 (de) Verfahren zur herstellung neuer d-homosteroide
LU78135A1 (de) Verfahren zur herstellung von benzodifuranen
DD135382A5 (de) Verfahren zur herstellung von triazolo-thieno-diazepin-1-onen